Shionogi
N. Kofi Addo, MPH, currently serves as a Clinical Quality Control Oversight Risk Manager at Shionogi Inc. and has been a researcher at Harvard T.H. Chan School of Public Health since February 2022, focusing on maternal health disparities. Prior experience includes roles as an In-House Clinical Research Associate at Integra LifeSciences, Research Coordinator at Temple University College of Public Health, and various positions at Acadia Pharmaceuticals, where responsibilities involved risk management and quality oversight for clinical studies. N. Kofi Addo has also contributed to maternal health research as a Graduate Research Assistant at Tufts University and Boston University, and has undertaken internships aimed at enhancing public health initiatives and compliance in clinical trials. Education credentials include a Master of Public Health from Boston University and a Bachelor of Science in Public Health from Rutgers University.
This person is not in any teams
This person is not in any offices
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.